New ASCO-CAP Guidelines for HER2 Testing - Srl
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Brittany Harvey on X: "Listen to the latest @ASCO Guidelines podcast episode to hear co-chairs @awolff and @DrKimAllison discuss this ASCO-CAP HER2 testing guideline update with me, including the implications for clinicians
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/9-Figure3-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
Mapping knowledgebase-specific evidence codes to AMP/ASCO/CAP... | Download Table
Schematic diagram of the ''Algorithm for evaluation of human epidermal... | Download Scientific Diagram
The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines | Journal of Clinical Pathology
Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows | BMC Medical Genomics | Full Text
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/ CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer | Virchows Archiv
2018 ASCO/CAP summary recommendations [original recommendations and... | Download Scientific Diagram
ASCO Guidelines
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
Summary of ASCO/CAP HER2 testing recommendations 2007 and 2013 | Download Table
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
ASCO 2020: HER2 Reclassification - Agendia Inc.
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
Identification of challenges and a framework for implementation of the AMP/ ASCO/CAP classification guidelines for reporting somatic variants - ScienceDirect
What's New in the 2020 Update to the CAP/ASCO ER/PR Testing Guidelines in Breast Cancer?
Second act for HER2, in gastric cancers - CAP TODAY
HER2 spectrum of expression according to ASCO/CAP guidelines. HER2-low... | Download Scientific Diagram
ASCO 2022 – Standing ovation and hope. - Cerba Research
Updated (2018) ASCO/CAP Guidelines for HER2 Testing in Breast Cancer - Insights
HER2 Status Determined by 2007 and 2013 ASCO/CAP Criteria, Respectively... | Download Table
ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia - ScienceDirect
